Hyoscine Butylbromide EP Impurity A
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

51-34-3Hyoscine Butylbromide EP Impurity A

● In Stock

Catalogue No.:VE009438
CAS No.:51-34-3
Mol. Formula:C17H21NO4
Mol. Weight:303.35 g/mol

Additional information on CAS 51-34-3

Parent drug

Hyoscine

IUPAC Name

(1R, 2R, 4S, 5S, 7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02, 4]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate

Pharmacopoeial Synonyms

Atropine EP Impurity F

Other Synonyms

6beta,7beta-Epoxy-3alpha-tropanyl S-(-)-tropate; Hyoscine; Scopolamine; 6,7-Epoxytropine tropate

Smile

CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4

InChI

InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11?,12-,13-,14+,15-,16+/m1/s1

Description

Hyoscine Butylbromide EP Impurity A also known in pharmacopoeias as Atropine EP Impurity F is a thoroughly characterized reference standard. It meets strict regulatory standards including those set by USP EMA JP and BP. This product is crucial for use in Abbreviated New Drug Applications (ANDA) New Drug Applications (NDA) and the commercial production of Hyoscine/ Atropine. Additionally it comes with a detailed Structure Elucidation Report (SER) ensuring its precision and dependability for a variety of analytical uses. Hyoscine Butylbromide EP Impurity A(CAS No: 51-34-3) or (1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2-phenylpropionate, is a belladonna alkaloid that used treatment of nausea, postoperative nausea, and vomiting, it is naturally occurring of tropane alkaloid isolated from Solanaceae family of plants.

References

Spinks, Anneliese, and Jason Wasiak. Scopolamine (Hyoscine) for Preventing and Treating Motion Sickness.” Cochrane Database of Systematic Reviews, June 2011, https://doi.org/10.1002/14651858.cd002851.pub4.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url